Our first news is that we’ve found some terrific services that we believe will help immensely if you are trading Novo Nordisk A/S – take a quick look through the following:
Beat The Market Analyzer: https://logistics-business-review.com/recommended-tool-for-NVO-investors (this is a fantastic tool – use this to analyze Novo Nordisk A/S in much more depth)
MM Publishing: https://logistics-business-review.com/mmpublishing-for-NVO-investors
Trading Code: https://logistics-business-review.com/tradingcode-for-NVO-investors
Trader HR: https://logistics-business-review.com/traderHR-for-NVO-investors
REPORTING FOR 2019-07-15 | LOGISTICS-BUSINESS-REVIEW.COM: We have conducted a deep analysis of how Novo Nordisk A/S ($NVO) has been trading over the last 2 weeks and the past day especially. On its latest session, Novo Nordisk A/S ($NVO) opened at 48.39, reaching a high of 48.4 and a low of 47.245 before closing at a price of 47.54. There was a total volume of 3323573.
VOLUME INDICATORS: We saw an accumulation-distribution index of 13054.93333, an on-balance volume of 48.94, chaikin money flow of 230.0 and a force index of 9.03905. There was an ease of movement rating of -0.00205, a volume-price trend of -2.19394 and a negative volume index of 1000.0.
VOLATILITY: We noted an average true range of 0.46562, bolinger bands of 50.16418, an upper bollinger band of 45.85082, lower bollinger band of 47.245, a bollinger high band indicator of 1.0, bollinger low band indicator of 1.0, a central keltner channel of 48.01167, high band keltner channel of 48.00167, low band keltner channel of 48.02167, a high band keltner channel indicator of 1.0 and a low band keltner channel indicator of 1.0. There was a donchian channel high band of 47.245, a donchian channel low band of 47.245, a donchian channel high band indicator of 1.0, and a donchian channel low band indicator of 1.0.
TREND: We calculated a Moving Average Convergence Divergence (MACD) of 0.03421, a MACD signal of 0.01901, a MACD difference of 0.01521, a fast Exponential Moving Average (EMA) indicator of 47.245, a slow Exponential Moving Average (EMA) indicator of 47.245, an Average Directional Movement Index (ADX) of unknown, an ADX positive of 20.0, an ADX negative of 20.0, a positive Vortex Indicator (VI) of 1.0, a negative VI of 1.0, a trend vortex difference of 0.01701, a trix of -4.26244, a Mass Index (MI) of 1.0, a Commodity Channel Index (CCI) of 66.66667, a Detrended Price Oscillator (DPO) of 2.29354, a KST Oscillator (KST) of -46.298 and a KST Oscillator (KST Signal) of -46.298 (leaving a KST difference of 7.69603). We also found an Ichimoku rating of 48.395, an Ichimoku B rating of 48.395, a Ichimoku visual trend A of 49.95699, an Ichimoku visual trend B of 49.9142, an Aroon Indicator (AI) up of 4.0 and an AI indicator down of 4.0. That left a difference of 4.0.
MOMENTUM: We found a Relative Strength Index (RSI) of 50.0, a Money Flow Index (MFI) of 51.55723, a True Strength Index (TSI) of -100.0, an ultimate oscillator of -101.44616, a stochastic oscillator of 11550.0, a stochastic oscillator signal of 11550.0, a Williams %R rating of 11450.0 and an awesome oscillator of 0.35267.
RETURNS: There was a daily return of -4.6298, a daily log return of 3.17685 and a cumulative return of 3.22785.
What the heck does all of this mean? If you are new to technical analysis, the above may be gibberish to you, and that’s OK (though we do advise learning these things). The bottom line is that AS OF 2019-07-15 (if you are reading this later, the analysis will be out of date), here is what our deep analysis of technical indicators are telling us for Novo Nordisk A/S ($NVO)…
For a more complete analysis, run all of this through the BTMA software. Also, to stay up to date with what is happening on Novo Nordisk A/S, we strongly advise Novo Nordisk A/S investors to subscribe to MarketBeat.com’s daily email newsletter for updates, news and analyst ratings on stocks like Novo Nordisk A/S – without this you are trading blind:
We will of course continue to cover the news and price action of Novo Nordisk A/S, but it’s easiest for you to just subscribe to MarketBeat’s newsletter above so you don’t miss anything.
DISCLAIMER: We are not registered investment advisers and the above analysis should be taken at face value only. We strongly advise against buying or selling Novo Nordisk A/S ($NVO) based solely on our analysis above, and are not responsible for any losses that you may incur if you choose make any investment decisions based on the above.